• Mon. Apr 15th, 2024

IIT Guwahati completes technology transfer to roll out the first recombinant vaccine for Swine Fever Virus

Indian Institute of Technology Guwahati successfully transferred a pioneering vaccine technology to BioMed Pvt. Ltd., a leading manufacturing company specializing in high-quality vaccines. This technology entails a recombinant vector vaccine designed specifically for combating the classical swine fever virus in pigs and wild boars, filling a significant gap in India’s vaccine landscape.

This first recombinant virus-based vaccine for pigs harnesses a reverse genetic platform pioneered and refined at IIT Guwahati. Swine fever, a highly contagious disease among pigs, poses a severe threat with a very high mortality rate, although it does not affect humans. In India, instances of this disease have been frequently observed in northeastern states, as well as in Bihar, Kerala, Punjab, Haryana, and Gujarat, among others.

The vaccine work was started in 2018-2019 through collaborative efforts between researchers from the Department of Biosciences and Bioengineering at IIT Guwahati, and Assam Agricultural University in Guwahati. Their research findings have been published in two papers, featured in Process Biochemistry and Archives of Virology journals.

Leave a Reply

Your email address will not be published. Required fields are marked *

WP Twitter Auto Publish Powered By : XYZScripts.com